;PMID: 8463133
;source_file_515.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..38] = [t:0..38]
;1)sentence:[e:43..92] = [t:43..92]
;2)section:[e:96..174] = [t:96..174]
;3)section:[e:178..229] = [t:178..229]
;4)sentence:[e:233..498] = [t:233..498]
;5)sentence:[e:499..616] = [t:499..616]
;6)sentence:[e:617..659] = [t:617..659]
;7)sentence:[e:660..948] = [t:660..948]
;8)sentence:[e:949..1129] = [t:949..1129]
;9)section:[e:1133..1177] = [t:1133..1177]

;section 0 Span:0..38
;Jpn J Cancer Res  1993 Feb;84(2):163-7
(SEC
  (FRAG (NNP:[0..3] Jpn) (NNP:[4..5] J) (NNP:[6..12] Cancer) (NNP:[13..16] Res)
        (CD:[18..22] 1993) (.:[23..28] Feb;8) (CD:[28..29] 4)
        (NN:[29..30] -LRB-) (NN:[30..31] 2) (NN:[31..32] -RRB-) (VBZ:[32..33] :)
        (CD:[33..35] 16) (CD:[35..38] 3-7)))

;sentence 1 Span:43..92
;Infrequent ras mutation in human stomach cancers.
;[54..57]:gene-rna:"ras"
;[76..91]:malignancy:"stomach cancers"
(SENT
  (NP-HLN
    (NP (JJ:[43..53] Infrequent) (NN:[54..57] ras) (NN:[58..66] mutation))
    (PP (IN:[67..69] in)
      (NP (JJ:[70..75] human)
         (NN:[76..83] stomach) (NNS:[84..91] cancers)))
    (.:[91..92] .)))

;section 2 Span:96..174
;Koshiba M, Ogawa O, Habuchi T, Hamazaki S, Shimada T, Takahashi R, Sugiyama
;T.
(SEC
  (FRAG (NNP:[96..103] Koshiba) (NNP:[104..106] M,) (NNP:[107..112] Ogawa)
        (NNP:[113..115] O,) (NNP:[116..123] Habuchi) (NNP:[124..125] T)
        (,:[125..126] ,) (NNP:[127..135] Hamazaki) (NNP:[136..137] S)
        (,:[137..138] ,) (NNP:[139..146] Shimada) (NNP:[147..148] T)
        (,:[148..149] ,) (NNP:[150..159] Takahashi) (NNP:[160..161] R)
        (,:[161..162] ,) (NNP:[163..171] Sugiyama) (NNP:[172..174] T.)))

;section 3 Span:178..229
;Department of Geriatric Medicine, Kyoto University.
(SEC
  (FRAG (NNP:[178..188] Department) (IN:[189..191] of)
        (NNP:[192..201] Geriatric) (NNP:[202..210] Medicine) (,:[210..211] ,)
        (NNP:[212..217] Kyoto) (NNP:[218..228] University) (.:[228..229] .)))

;sentence 4 Span:233..498
;Mutations of ras oncogenes in 37 human stomach cancers and 13 adenomas were 
;investigated with regard to the histological phenotypes using polymerase
;chain  reaction (PCR), allele-specific oligonucleotide hybridization and/or
;direct  sequencing of the PCR products.
;[246..249]:gene-rna:"ras"
;[272..287]:malignancy:"stomach cancers"
;[295..303]:malignancy:"adenomas"
;[372..382]:gene-protein:"polymerase"
(SENT
  (S
    (NP-SBJ-1
      (NP (NNS:[233..242] Mutations))
      (PP (IN:[243..245] of)
        (NP (NN:[246..249] ras) (NNS:[250..259] oncogenes)))
      (PP (IN:[260..262] in)
        (NP
          (NP (CD:[263..265] 37) (JJ:[266..271] human)
             (NN:[272..279] stomach) (NNS:[280..287] cancers))
          (CC:[288..291] and)
          (NP (CD:[292..294] 13) (NNS:[295..303] adenomas)))))
    (VP (VBD:[304..308] were)
      (VP (VBN:[310..322] investigated)
        (NP-1 (-NONE-:[322..322] *))
        (PP (IN:[323..327] with)
          (NP
            (NP (NN:[328..334] regard))
            (PP (TO:[335..337] to)
              (NP (DT:[338..341] the) (JJ:[342..354] histological)
                  (NNS:[355..365] phenotypes)))))
        (S-MNR
          (NP-SBJ (-NONE-:[365..365] *))
          (VP (VBG:[366..371] using)
            (NP
              (NP
                (NP (NN:[372..382] polymerase) (NN:[383..388] chain)
                    (NN:[390..398] reaction))
                (NP (-LRB-:[399..400] -LRB-) (NN:[400..403] PCR)
                    (-RRB-:[403..404] -RRB-)))
              (,:[404..405] ,)
              (NP
                (ADJP (NN:[406..412] allele) (HYPH:[412..413] -)
                      (JJ:[413..421] specific))
                (NN:[422..437] oligonucleotide) (NN:[438..451] hybridization))
              (CC:[452..458] and/or)
              (NP
                (NP (JJ:[459..465] direct) (NN:[467..477] sequencing))
                (PP (IN:[478..480] of)
                  (NP (DT:[481..484] the) (NN:[485..488] PCR)
                      (NNS:[489..497] products)))))))))
    (.:[497..498] .)))

;sentence 5 Span:499..616
;The ras mutation was found only in one case  (2.7%), the histology of which
;was poorly differentiated adenocarcinoma.
;[503..506]:gene-rna:"ras"
;[507..515]:variation-event:"mutation"
;[579..615]:malignancy:"poorly differentiated adenocarcinoma"
(SENT
  (S
    (NP-SBJ-2 (DT:[499..502] The) (NN:[503..506] ras) (NN:[507..515] mutation))
    (VP (VBD:[516..519] was)
      (VP (VBN:[520..525] found)
        (NP-2 (-NONE-:[525..525] *))
        (ADVP (RB:[526..530] only))
        (PP (IN:[531..533] in)
          (NP
            (NP (CD:[534..537] one) (NN:[538..542] case)
              (PRN (-LRB-:[544..545] -LRB-)
                (NP (CD:[545..548] 2.7) (NN:[548..549] %))
                (-RRB-:[549..550] -RRB-)))
            (,:[550..551] ,)
            (SBAR
              (WHNP-1
                (NP (DT:[552..555] the) (NN:[556..565] histology))
                (WHPP (IN:[566..568] of)
                  (WHNP (WDT:[569..574] which))))
              (S
                (NP-SBJ-1 (-NONE-:[574..574] *T*))
                (VP (VBD:[575..578] was)
                  (NP-PRD
                    (ADJP (RB:[579..585] poorly) (JJ:[586..600] differentiated))
                    (NN:[601..615] adenocarcinoma)))))))))
    (.:[615..616] .)))

;sentence 6 Span:617..659
;We  found no mutation in stomach adenomas.
;[642..658]:malignancy:"stomach adenomas"
(SENT
  (S
    (NP-SBJ (PRP:[617..619] We))
    (VP (VBD:[621..626] found)
      (NP (DT:[627..629] no) (NN:[630..638] mutation))
      (PP-LOC (IN:[639..641] in)
        (NP (NN:[642..649] stomach) (NNS:[650..658] adenomas))))
    (.:[658..659] .)))

;sentence 7 Span:660..948
;The mutation consisted of a  guanine-to-adenine transition in the first base
;of codon 13 of c-Ki-ras which  replaced wild-type glycine with serine,
;indicating that a putative  glycine-to-aspartic acid change is not
;necessarily the critical event for  c-Ki-ras gene activation in codon 13.
;[664..672]:variation-event:"mutation"
;[689..696]:variation-state-original:"guanine"
;[700..707]:variation-state-altered:"adenine"
;[726..748]:variation-location:"first base of codon 13"
;[752..760]:gene-rna:"c-Ki-ras"
;[787..794]:variation-state-original:"glycine"
;[800..806]:variation-state-altered:"serine"
;[836..843]:variation-state-original:"glycine"
;[847..860]:variation-state-altered:"aspartic acid"
;[911..919]:gene-rna:"c-Ki-ras"
;[939..947]:variation-location:"codon 13"
(SENT
  (S
    (NP-SBJ (DT:[660..663] The) (NN:[664..672] mutation))
    (VP (VBD:[673..682] consisted)
      (PP (IN:[683..685] of)
        (NP
          (NP
            (NP (DT:[686..687] a)
              (NML
                (NML (NN:[689..696] guanine))
                (HYPH:[696..697] -)
                (PP (TO:[697..699] to) (HYPH:[699..700] -)
                  (NP (NN:[700..707] adenine))))
              (NN:[708..718] transition))
            (PP-LOC (IN:[719..721] in)
              (NP
                (NP (DT:[722..725] the) (JJ:[726..731] first)
                    (NN:[732..736] base))
                (PP (IN:[737..739] of)
                  (NP
                    (NP (NN:[740..745] codon) (CD:[746..748] 13))
                    (PP (IN:[749..751] of)
                      (NP (NN:[752..760] c-Ki-ras))))))))
          (SBAR
            (WHNP-1 (WDT:[761..766] which))
            (S
              (NP-SBJ-1 (-NONE-:[766..766] *T*))
              (VP (VBD:[768..776] replaced)
                (NP (JJ:[777..786] wild-type) (NN:[787..794] glycine))
                (PP (IN:[795..799] with)
                  (NP (NN:[800..806] serine))))))))
      (,:[806..807] ,)
      (S-ADV
        (NP-SBJ (-NONE-:[807..807] *))
        (VP (VBG:[808..818] indicating)
          (SBAR (IN:[819..823] that)
            (S
              (NP-SBJ (DT:[824..825] a) (JJ:[826..834] putative)
                (NML
                  (NML (NN:[836..843] glycine))
                  (HYPH:[843..844] -)
                  (PP (TO:[844..846] to) (HYPH:[846..847] -)
                    (NP (JJ:[847..855] aspartic) (NN:[856..860] acid))))
                (NN:[861..867] change))
              (VP (VBZ:[868..870] is) (RB:[871..874] not)
                (ADVP (RB:[875..886] necessarily))
                (NP-PRD (DT:[887..890] the) (JJ:[891..899] critical)
                        (NN:[900..905] event))
                (PP (IN:[906..909] for)
                  (NP (NN:[911..919] c-Ki-ras) (NN:[920..924] gene)
                      (NN:[925..935] activation)))))))))
    (PP-LOC (IN:[936..938] in)
      (NP (NN:[939..944] codon) (CD:[945..947] 13)))
    (.:[947..948] .)))

;sentence 8 Span:949..1129
;These results further confirm the  infrequency of ras mutation in stomach
;tumors and also suggest that ras  mutations are not specific to the
;differentiated type of stomach cancer.
;[999..1002]:gene-rna:"ras"
;[1015..1029]:malignancy:"stomach tumors"
;[1052..1055]:gene-rna:"ras"
;[1091..1128]:malignancy:"differentiated type of stomach cancer"
(SENT
  (S
    (NP-SBJ (DT:[949..954] These) (NNS:[955..962] results))
    (VP
      (VP
        (ADVP (RB:[963..970] further))
        (VBP:[971..978] confirm)
        (NP
          (NP (DT:[979..982] the) (NN:[984..995] infrequency))
          (PP (IN:[996..998] of)
            (NP (NN:[999..1002] ras) (NN:[1003..1011] mutation))))
        (PP (IN:[1012..1014] in)
          (NP (NN:[1015..1022] stomach) (NNS:[1023..1029] tumors))))
      (CC:[1030..1033] and)
      (VP
        (ADVP (RB:[1034..1038] also))
        (VBP:[1039..1046] suggest)
        (SBAR (IN:[1047..1051] that)
          (S
            (NP-SBJ (NN:[1052..1055] ras) (NNS:[1057..1066] mutations))
            (VP (VBP:[1067..1070] are) (RB:[1071..1074] not)
              (ADJP-PRD (JJ:[1075..1083] specific)
                (PP (TO:[1084..1086] to)
                  (NP
                    (NP (DT:[1087..1090] the) (JJ:[1091..1105] differentiated)
                        (NN:[1106..1110] type))
                    (PP (IN:[1111..1113] of)
                      (NP (NN:[1114..1121] stomach) (NN:[1122..1128] cancer)))))))))))
    (.:[1128..1129] .)))

;section 9 Span:1133..1177
;PMID: 8463133 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1133..1137] PMID) (::[1137..1138] :) (CD:[1139..1146] 8463133)
        (NN:[1147..1148] -LSB-) (NNP:[1148..1154] PubMed) (::[1155..1156] -)
        (NN:[1157..1164] indexed) (IN:[1165..1168] for)
        (NNP:[1169..1177] MEDLINE-RSB-)))
